Hepion Pharmaceuticals HEPA
OTC HEPA
$0.12 -0.01 (-7.62%)
As of: Oct 23, 2026 · 12:25 PM EDT

Hepion Pharmaceuticals (HEPA) Return on Sales [ROS] (2024 - 2025)

Updated

Analysis

Hepion Pharmaceuticals (HEPA) Return on Sales [ROS] (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn 13.44%
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn 19.44%
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn 18.08%
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn 25.18%
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn 21.65%
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn 29.48%
10 Hepion Pharmaceuticals 1.24 Mn -10.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -6,504.46%
Jun 30, 2025 -35,871.58%
Jun 30, 2024 -17,167.01%
API Access

Hepion Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HEPA&period=max&api_key=YOUR_API_KEY